J Neurol Neurosurg Psychiatry 2002;72:708712.ArticlePubMedPMC 50
What most articles get wrong about "medical necessity" Most insurance explainer articles claim GLP-1 medications are covered "when medically necessary." This is technically true but misleading in a way that costs patients time and money
FDAs evolving policy changes may be subject to court challenges by compounding pharmacies or outsourcing facilities that find themselves the target of FDAs enforcement activities, particularly in the post Loper Bright world.
50 In August 2025, the US Food and Drug Administration approved semaglutide to treat MASH in adults with moderate-to-advanced fibrosis
GLP-1 (glucagon-like peptide-1) receptor agonists mimic a natural gut hormone to slow digestion, reduce appetite, and regulate blood sugar
Hypoglycemia can lead to dizziness, loss of consciousness, seizure, coma and even death